Dubin Glenn 4
4 · C4 Therapeutics, Inc. · Filed Mar 16, 2021
Insider Transaction Report
Form 4
Dubin Glenn
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-12+41,200→ 41,200 totalExercise: $44.64Exp: 2031-03-11→ Common Stock (41,200 underlying)
Footnotes (1)
- [F1]One-third of this option shall vest and become exercisable on March 12, 2022, with the remainder vesting in eight equal quarterly installments thereafter.